Recourse vs NonRecourse in Healthcare
What Every CFO Needs to Know
Patient financing has historically been treated as a revenue cycle function. That made sense when patient financial responsibility represented a smaller and more predictable share of total health system revenue. That is no longer the scenario.
Patient responsibility now represents more than 30% of total net patient revenue and is growing. With 41% of American adults carrying healthcare debt and 1 in 3 hospitals reporting bad debt exceeding $10,000 per patient case, the structure of a patient financing arrangement has direct implications for balance-sheet treatment, bond covenant compliance, reserve requirements, and operating margin.
The specific question every CFO should be asking is this: when your health system enters a patient financing arrangement, who carries the risk if the patient does not pay?
The answer determines whether your financing program is a revenue recovery tool or a contingent liability.
The Core Distinction: Where Does Risk Live?
In a recourse arrangement, the health system transfers patient receivables to a financing or collection company but retains contingent liability for those accounts. If the patient does not repay, the health system may be required to repurchase the account, refund a portion of the advance, or absorb a reserve charge against future advances. The risk has only been temporarily and conditionally transferred.
In a non-recourse arrangement, the financing company purchases the patient receivable and assumes all credit risk associated with that account. If the patient does not repay, the financing company absorbs the loss. The health system retains the revenue it received and has no further financial obligation related to that account.
The risk has been transferred permanently and completely.
Why This Matters for CFOs
For health systems operating on thin margins, the difference between recourse and non-recourse financing is not an accounting detail. It is a material financial risk management decision.
Recourse-based financing arrangements may create balance-sheet reserves, bond covenant exposure, cash flow timing risk, and contingent liability. Non-recourse financing eliminates these risks by transferring repayment risk to the financing company.
CURAEPay, the patient payment financing solution within Curae’s Patient Financial Access Platform, operates on a fully non-recourse model, funding the patient’s responsibility upfront within 48 hours, with no balance-sheet exposure or reserve requirements for the health system.
What CFOs Should Evaluate
Not all non-recourse patient financing platforms are structurally equivalent. CFOs evaluating vendors should look beyond the basic recourse vs. non-recourse designation and examine:
• Whether the non-recourse structure is complete
• The financing company’s source of capital
• Regulatory standing under Regulation B and Regulation Z
• Pricing transparency
• Implementation timeline
• Provider brand impact
• Patient financial experience
• Ability to support a revolving line of credit at scale
A platform approving up to 90%+ of applicants means more potential bad debt can be converted to funded receivables.
Key Takeaway
Recourse patient financing can create contingent liabilities, reserve obligations, and cash flow uncertainty. Non-recourse financing permanently transfers repayment risk to the financing company, helping health systems protect revenue, reduce exposure, and improve financial predictability.
For CFOs, the decision is not simply which patient financing vendor to choose. The decision is who carries the risk.
Read the Full Article
Learn why the distinction between recourse and non-recourse debt matters for balance-sheet treatment, bond covenant exposure, reserve requirements, and patient financing strategy.
Questions?
Gary Johnson
Chief Growth Officer, CURAE®
gary.johnson@curae.com
678-643-9801
Curae’s patient financing program is managed by Curae and its affiliated companies, offering and servicing consumer credit accounts issued by a federally regulated bank to patients. Net of Curae’s discount applied against the balance liquidated, based on each individual’s risk profile.
Actual results may vary and are dependent on implementing best practices, the patient population served, and local demographics.
Curae credit lines are issued by The Bank of Missouri, Perryville, MO.